Integrated Wealth Concepts LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1737109 WALTHAM, MA

Position in ALNY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,014,492

+$236,397 QoQ

Shares Held

6,692

+24.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#329

of 784 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Integrated Wealth Concepts LLC holds $51,111,338 across 302 Biotechnology names. ALNY ranks #6 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	152,216	$8,709,799
2	INVA	Innoviva, Inc.	350,575	$7,961,558
3	EXEL	Exelixis, Inc.	69,926	$3,804,673
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6,994	$3,474,129
5	DNLI	Denali Therapeutics Inc.	102,241	$2,629,638
6	ALNY	Alnylam Pharmaceuticals, Inc. This page	6,692	$2,014,492
7	INCY	Incyte Corp	17,318	$1,963,168
8	TLX	Telix Pharmaceuticals Ltd	164,397	$1,895,497

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,014,492	6,692	+24.5%	Shares	Sole	2026-08-12
2026-03-31	$1,778,095	5,374	+26.7%	Shares	Other	2026-05-15
2025-12-31	$1,686,036	4,240	-8.5%	Shares	Other	2026-02-13
2025-09-30	$2,114,016	4,636	+34.6%	Shares	Other	2025-11-14
2025-06-30	$1,123,380	3,445	+25.8%	Shares	Other	2025-08-14
2025-03-31	$739,584	2,739	+9.0%	Shares	Other	2025-05-15
2024-12-31	$591,098	2,512	+7.5%	Shares	Other	2025-02-14
2024-09-30	$642,470	2,336	+1.0%	Shares	Other	2024-11-14
2024-06-30	$562,302	2,314	-0.3%	Shares	Other	2024-08-14
2024-03-31	$346,724	2,320	+1.4%	Shares	Other	2024-05-15
2023-12-31	$438,137	2,289	+0.7%	Shares	Other	2024-02-13
2023-09-30	$402,725	2,274	+0.1%	Shares	Other	2023-11-15
2023-06-30	$431,353	2,271	-5.6%	Shares	Other	2023-08-15
2023-03-31	$481,969	2,406	—	Shares	Other	2023-05-03
No filing history on record for this holder in this stock.